179 related articles for article (PubMed ID: 22119935)
1. Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans.
Hitz K; Heekeren K; Obermann C; Huber T; Juckel G; Kawohl W
Psychopharmacology (Berl); 2012 Jun; 221(3):389-96. PubMed ID: 22119935
[TBL] [Abstract][Full Text] [Related]
2. Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants.
Simmons JG; Nathan PJ; Berger G; Allen NB
Psychopharmacology (Berl); 2011 Sep; 217(1):101-10. PubMed ID: 21465243
[TBL] [Abstract][Full Text] [Related]
3. The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission.
Oliva J; Leung S; Croft RJ; O'Neill BV; O'Kane J; Stout J; Phan KL; Nathan PJ
Hum Psychopharmacol; 2010 Jul; 25(5):423-7. PubMed ID: 20589921
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity.
Juckel G; Gallinat J; Riedel M; Sokullu S; Schulz C; Möller HJ; Müller N; Hegerl U
Schizophr Res; 2003 Nov; 64(2-3):115-24. PubMed ID: 14613676
[TBL] [Abstract][Full Text] [Related]
5. Response prediction to antidepressants using scalp and source-localized loudness dependence of auditory evoked potential (LDAEP) slopes.
Jaworska N; Blondeau C; Tessier P; Norris S; Fusee W; Blier P; Knott V
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():100-7. PubMed ID: 23360662
[TBL] [Abstract][Full Text] [Related]
6. High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans.
O'Neill BV; Croft RJ; Leung S; Oliver C; Phan KL; Nathan PJ
Psychopharmacology (Berl); 2007 Nov; 195(1):85-93. PubMed ID: 17646968
[TBL] [Abstract][Full Text] [Related]
7. Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans.
O'Neill BV; Guille V; Croft RJ; Leung S; Scholes KE; Phan KL; Nathan PJ
Hum Psychopharmacol; 2008 Jun; 23(4):301-12. PubMed ID: 18213738
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans.
O'Neill BV; Croft RJ; Leung S; Guille V; Galloway M; Phan KL; Nathan PJ
Psychopharmacology (Berl); 2006 Sep; 188(1):92-9. PubMed ID: 16896953
[TBL] [Abstract][Full Text] [Related]
9. Loudness dependence of evoked dipole source activity during acute serotonin challenge in females.
Norra C; Becker S; Bröcheler A; Kawohl W; Kunert HJ; Buchner H
Hum Psychopharmacol; 2008 Jan; 23(1):31-42. PubMed ID: 17868194
[TBL] [Abstract][Full Text] [Related]
10. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex.
Wutzler A; Winter C; Kitzrow W; Uhl I; Wolf RJ; Heinz A; Juckel G
Neuropsychopharmacology; 2008 Dec; 33(13):3176-81. PubMed ID: 18463629
[TBL] [Abstract][Full Text] [Related]
11. Evidence for sex differences in the loudness dependence of the auditory evoked potential in humans.
Oliva JL; Leung S; Croft RJ; O'Neill BV; Stout JC; Nathan PJ
Hum Psychopharmacol; 2011 Mar; 26(2):172-6. PubMed ID: 21455974
[TBL] [Abstract][Full Text] [Related]
12. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects?
Uhl I; Gorynia I; Gallinat J; Mulert C; Wutzler A; Heinz A; Juckel G
Hum Psychopharmacol; 2006 Oct; 21(7):463-71. PubMed ID: 17029304
[TBL] [Abstract][Full Text] [Related]
13. Loudness- and time-dependence of auditory evoked potentials is blunted by the NMDA channel blocker MK-801.
Teichert T
Psychiatry Res; 2017 Oct; 256():202-206. PubMed ID: 28645081
[TBL] [Abstract][Full Text] [Related]
14. Preserved Serotonergic Activity in Early-Onset Parkinson's Disease.
Park HK; Lee JJ; Park YM
Can J Neurol Sci; 2020 May; 47(3):344-349. PubMed ID: 31685057
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
[TBL] [Abstract][Full Text] [Related]
16. Prediction of long-term treatment response to selective serotonin reuptake inhibitors (SSRIs) using scalp and source loudness dependence of auditory evoked potentials (LDAEP) analysis in patients with major depressive disorder.
Lee BH; Park YM; Lee SH; Shim M
Int J Mol Sci; 2015 Mar; 16(3):6251-65. PubMed ID: 25794285
[TBL] [Abstract][Full Text] [Related]
17. The loudness dependence of auditory evoked potentials (LDAEP) as an indicator of serotonergic dysfunction in patients with predominant schizophrenic negative symptoms.
Wyss C; Hitz K; Hengartner MP; Theodoridou A; Obermann C; Uhl I; Roser P; Grünblatt E; Seifritz E; Juckel G; Kawohl W
PLoS One; 2013; 8(7):e68650. PubMed ID: 23874705
[TBL] [Abstract][Full Text] [Related]
18. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings.
O'Neill BV; Croft RJ; Nathan PJ
Hum Psychopharmacol; 2008 Jul; 23(5):355-70. PubMed ID: 18421800
[TBL] [Abstract][Full Text] [Related]
19. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline.
Guille V; Croft RJ; O'Neill BV; Illic S; Phan KL; Nathan PJ
Hum Psychopharmacol; 2008 Apr; 23(3):231-41. PubMed ID: 18196604
[TBL] [Abstract][Full Text] [Related]
20. The Loudness Dependence of Auditory Evoked Potentials (LDAEP) in individuals at risk for developing bipolar disorders and schizophrenia.
Hagenmuller F; Heekeren K; Meier M; Theodoridou A; Walitza S; Haker H; Rössler W; Kawohl W
Clin Neurophysiol; 2016 Feb; 127(2):1342-1350. PubMed ID: 26639170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
